Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.

MLA

Knisely, Anne, et al. “Efficacy, Safety, and Feasibility of Apixaban for Postoperative Venous Thromboembolism Prophylaxis Following Open Gynecologic Cancer Surgery at a Comprehensive Cancer Center.” Gynecologic Oncology, vol. 183, Apr. 2024, pp. 120–25. EBSCOhost, https://doi.org/10.1016/j.ygyno.2024.01.039.

APA

Knisely, A., Iniesta, M. D., Batman, S., Meyer, L. A., Soliman, P. T., Cain, K. E., Marten, C., Chisholm, G., Schmeler, K. M., Taylor, J. S., & Fleming, N. D. (2024). Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecologic Oncology, 183, 120–125. https://doi.org/10.1016/j.ygyno.2024.01.039

Chicago

Knisely, Anne, Maria D. Iniesta, Samantha Batman, Larissa A. Meyer, Pamela T. Soliman, Katherine E. Cain, Claire Marten, et al. 2024. “Efficacy, Safety, and Feasibility of Apixaban for Postoperative Venous Thromboembolism Prophylaxis Following Open Gynecologic Cancer Surgery at a Comprehensive Cancer Center.” Gynecologic Oncology 183 (April): 120–25. doi:10.1016/j.ygyno.2024.01.039.